DRAK2 aggravates nonalcoholic fatty liver disease progression through SRSF6-associated RNA alternative splicing.
Li Y, Xu J, Lu Y, Bian H, Yang L, Wu H, Zhang X, Zhang B, Xiong M, Chang Y, Tang J, Yang F, Zhao L, Li J, Gao X, Xia M, Tan M, Li J.
Li Y, et al. Among authors: xu j.
Cell Metab. 2021 Oct 5;33(10):2004-2020.e9. doi: 10.1016/j.cmet.2021.09.008.
Cell Metab. 2021.
PMID: 34614409
Free article.